| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/07/2023 | 85.87% | BTIG | $6 → $5 | Maintains | Buy |
| 03/29/2023 | 123.05% | TD Cowen | $8 → $6 | Maintains | Outperform |
| 11/09/2022 | 85.87% | Stephens & Co. | $16 → $5 | Maintains | Overweight |
| 11/08/2022 | 123.05% | BTIG | $15 → $6 | Maintains | Buy |
| 11/04/2022 | — | William Blair | Downgrades | Outperform → Market Perform | |
| 08/17/2022 | 755.02% | Oppenheimer | $48 → $23 | Maintains | Outperform |
| 08/15/2022 | 457.62% | BTIG | $19 → $15 | Maintains | Buy |
| 07/18/2022 | 1684.39% | Oppenheimer | → $48 | Assumes | → Outperform |
| 01/07/2022 | — | Stephens & Co. | Initiates Coverage On | → Overweight | |
| 05/03/2021 | 1870.26% | BTIG | → $53 | Initiates Coverage On | → Buy |
| 01/22/2021 | 1870.26% | Oppenheimer | → $53 | Initiates Coverage On | → Outperform |
| 10/30/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 09/10/2020 | 643.49% | Cowen & Co. | → $20 | Initiates Coverage On | → Outperform |
What is the target price for DermTech (DMTK)?
The latest price target for DermTech (NASDAQ: DMTK) was reported by BTIG on August 7, 2023. The analyst firm set a price target for $5.00 expecting DMTK to rise to within 12 months (a possible 85.87% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for DermTech (DMTK)?
The latest analyst rating for DermTech (NASDAQ: DMTK) was provided by BTIG, and DermTech maintained their buy rating.
When is the next analyst rating going to be posted or updated for DermTech (DMTK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DermTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DermTech was filed on August 7, 2023 so you should expect the next rating to be made available sometime around August 7, 2024.
Is the Analyst Rating DermTech (DMTK) correct?
While ratings are subjective and will change, the latest DermTech (DMTK) rating was a maintained with a price target of $6.00 to $5.00. The current price DermTech (DMTK) is trading at is $2.69, which is out of the analyst's predicted range.